- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 100
- consistent
Artificial pancreas may improve glucose control in type 1 diabetes
Última actualización 18 de agosto de 2026
Key finding
HCL had a lower mean blood glucose of 6.93 ± 0.99 mmol/L compared to MDI's 8.03 ± 2.17 mmol/L.
Android‐HCL therapy compared to insulin multi‐injection therapy in patients with type 1 diabetes.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
Android‐HCL therapy compared to insulin multi‐injection therapy in patients with type 1 diabetes.
Clinical relevance
This study evaluated Android‐HCL therapy compared to insulin multi‐injection therapy in patients with type 1 diabetes.
Keep in mind
Limitations were not clearly described in the extracted text.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Shaohua L, Pin L, Haosi L, et al. Efficacy and Safety of Artificial Pancreas in Patients with Type 1 Diabetes Mellitus. Case Reports in Endocrinology. 2026;2026. doi:10.1155/crie/8925266
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Hybrid closed-loop system, Insulin therapy and Blood glucose, Hypoglycemia events, Time above range, and 2 more.
This study contributes evidence to
Primary intervention
Hybrid closed-loop system
Primary outcomes
- Blood glucose
- Hypoglycemia events
- Time above range
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
6
Related topics
10
Evidence pairs
1447
Related studies
Why it is useful
- Contributes to 10 evidence relationships
- Includes primary outcome data
- Linked to 6 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Relación de evidencia
Insulin Delivery Systems and CGM Time in Range
Evidencia relacionada
Relación de evidencia
Insulin Delivery Systems and Hypoglycemia
Guardar evidencia
Relación de evidencia
Insulin Delivery Systems and Fasting Glucose
Guardar evidencia
Core evidence
Study findings
The primary outcomes reported in this study.
Hypoglycemia events
Hybrid closed-loop system → Hypoglycemia events
Hybrid closed-loop system → Hypoglycemia events
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 60
- generally_consistent
Time above range
Hybrid closed-loop system → Time above range
Hybrid closed-loop system → Time above range
- EvidenceScore™
- 79
- Strong
- ImpactScore™
- 88
- Very Positive
- ConsistencyScore™
- 100
- consistent
Time below range
Hybrid closed-loop system → Time below range
Hybrid closed-loop system → Time below range
- EvidenceScore™
- 78
- Strong
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 67
- generally_consistent
- EvidenceScore™
- 88
- Strong
- ImpactScore™
- 81
- Positive
- ConsistencyScore™
- 71
- generally_consistent
- EvidenceScore™
- 78
- Strong
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 67
- generally_consistent
- EvidenceScore™
- Strong
- Score 79 · Based on 3 studies
- ImpactScore™
- 67
- Slightly Positive
- ConsistencyScore™
- 35
- mixed
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 35
- mixed
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- 82
- Strong
- ImpactScore™
- 70
- Positive
- ConsistencyScore™
- 60
- generally_consistent
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Insulin Delivery Systems and CGM Time in Range, Insulin Delivery Systems and Hypoglycemia.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Insulin Delivery Systems → CGM Time in Range
Devices & Technology
- EvidenceScore™
- 88
- Strong
- ImpactScore™
- 81
- Positive
- ConsistencyScore™
- 71
- generally_consistent
Insulin Delivery Systems → Hypoglycemia
Devices & Technology
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 60
- generally_consistent
Incluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
CGM Time in Range Evidence Hub
All studies measuring CGM Time in Range
Measures CGM Time in Range as a key outcome.
Insulin Delivery Systems Evidence Hub
All studies on Insulin Delivery Systems
Contributes to Insulin Delivery Systems evidence base.
Hypoglycemia Evidence Hub
All studies measuring Hypoglycemia
Measures Hypoglycemia as a key outcome.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Hybrid closed-loop system and Time in range
21 results
All studies on Hybrid closed-loop system and Hypoglycemia events
5 results
All studies on Hybrid closed-loop system
21 results
All studies measuring Time in range
21 results
All studies measuring Hypoglycemia events
5 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Insulin Delivery Systems improve CGM Time in Range?
Insulin Delivery Systems may improve CGM Time in Range.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Strong | EvidenceScore™ 87.7 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study
- 2
Time above range
EvidenceScore™ Strong | EvidenceScore™ 78.6 | strong positive | ConsistencyScore™ Consistent | 1 study
- 3
Time below range
EvidenceScore™ Strong | EvidenceScore™ 78.3 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study
Why this answer: This answer is based on 38 supporting studies with generally consistent results and a positive effect signal.
Does Insulin Delivery Systems affect hypoglycemia?
Insulin Delivery Systems may affect hypoglycemia.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
Hypoglycemia events
EvidenceScore™ Strong | EvidenceScore™ 84.7 | neutral | ConsistencyScore™ Generally Consistent | 1 study
Why this answer: This answer is based on 9 supporting studies with generally consistent results and a positive effect signal.
Does Insulin Delivery Systems improve fasting glucose?
Insulin Delivery Systems may improve fasting glucose.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Blood glucose
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.
Do Insulin Therapies improve CGM Time in Range?
Insulin Therapies may improve CGM Time in Range.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
Time below range
EvidenceScore™ Strong | EvidenceScore™ 85.1 | neutral | ConsistencyScore™ Unclear | 1 study
- 2
Time in range
EvidenceScore™ Strong | EvidenceScore™ 81.8 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study
- 3
Time above range
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is based on 11 supporting studies with generally consistent results and a positive effect signal.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Sin anuncios. Sin rastreo.
Centrada en la evidencia, no en la publicidad.
Segura y privada
Tus datos siempre están protegidos.
Siempre al día
Se agregan nuevos estudios todos los días.
